MX2010006880A - Formulaciones estables de sales de elsamitrucina. - Google Patents

Formulaciones estables de sales de elsamitrucina.

Info

Publication number
MX2010006880A
MX2010006880A MX2010006880A MX2010006880A MX2010006880A MX 2010006880 A MX2010006880 A MX 2010006880A MX 2010006880 A MX2010006880 A MX 2010006880A MX 2010006880 A MX2010006880 A MX 2010006880A MX 2010006880 A MX2010006880 A MX 2010006880A
Authority
MX
Mexico
Prior art keywords
salt formulations
elsamitrucin salt
stable
formulations
stable elsamitrucin
Prior art date
Application number
MX2010006880A
Other languages
English (en)
Inventor
Ashok Gore
Kwok Yin Tsang
Original Assignee
Spectrum Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spectrum Pharmaceuticals Inc filed Critical Spectrum Pharmaceuticals Inc
Publication of MX2010006880A publication Critical patent/MX2010006880A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se proporcionan formulaciones que contienen formas estables de sales de elsamitrucina. Estas formulaciones son útiles para tratar enfermedades y condiciones neoplásticas.
MX2010006880A 2007-12-19 2008-12-19 Formulaciones estables de sales de elsamitrucina. MX2010006880A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1518307P 2007-12-19 2007-12-19
PCT/US2008/087683 WO2009086108A1 (en) 2007-12-19 2008-12-19 Stable elsamitrucin salt formulations

Publications (1)

Publication Number Publication Date
MX2010006880A true MX2010006880A (es) 2010-08-18

Family

ID=40510638

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010006880A MX2010006880A (es) 2007-12-19 2008-12-19 Formulaciones estables de sales de elsamitrucina.

Country Status (14)

Country Link
US (1) US20110251143A1 (es)
EP (1) EP2222276A1 (es)
JP (2) JP5788175B2 (es)
KR (1) KR20100101655A (es)
CN (1) CN102006859A (es)
AU (1) AU2008342992A1 (es)
BR (1) BRPI0820811A2 (es)
CA (1) CA2709227A1 (es)
IL (1) IL206473A (es)
MX (1) MX2010006880A (es)
NZ (1) NZ586166A (es)
RU (1) RU2491056C2 (es)
WO (1) WO2009086108A1 (es)
ZA (1) ZA201004179B (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518589A (en) * 1983-10-03 1985-05-21 Bristol-Myers Company BBM-2478 Antibiotic complex
ZA923818B (en) * 1991-05-30 1993-11-25 Bristol Myers Squibb Co Chemical modification of 2"-amino group in elsamicin A
US5508268A (en) * 1993-08-12 1996-04-16 Bristol-Myers Squibb Parenteral elsamitrucin formulations
RU2105569C1 (ru) * 1995-06-05 1998-02-27 Индивидуальное частное предприятие Фирма "Брынцалов" Способ получения лекарственной формы противоопухолевого антибиотика
CN1268624C (zh) * 2000-10-20 2006-08-09 伊莱利利公司 6－羟基－3－(4－[2－(哌啶－1－基)乙氧基]苯氧基)－2－(4－甲氧基苯基)苯并[b]噻吩盐酸盐的新晶形
US20070293445A1 (en) * 2006-06-15 2007-12-20 Spectrum Pharmaceuticals, Inc. Stable Elsamitrucin Salts Suitable for Pharmaceutical Formulations
MX2008015971A (es) * 2007-05-24 2009-01-12 Spectrum Pharmaceuticals Inc Sales de elsamitrucina estables adecuadas para formulaciones farmaceuticas.

Also Published As

Publication number Publication date
US20110251143A1 (en) 2011-10-13
EP2222276A1 (en) 2010-09-01
KR20100101655A (ko) 2010-09-17
JP2011507899A (ja) 2011-03-10
AU2008342992A1 (en) 2009-07-09
AU2008342992A2 (en) 2010-07-08
IL206473A (en) 2015-09-24
BRPI0820811A2 (pt) 2018-03-27
RU2491056C2 (ru) 2013-08-27
ZA201004179B (en) 2011-02-23
RU2010129518A (ru) 2012-01-27
IL206473A0 (en) 2010-12-30
NZ586166A (en) 2012-06-29
WO2009086108A1 (en) 2009-07-09
JP2014114313A (ja) 2014-06-26
CN102006859A (zh) 2011-04-06
CA2709227A1 (en) 2009-07-09
JP5788175B2 (ja) 2015-09-30

Similar Documents

Publication Publication Date Title
TN2011000293A1 (en) Protein kinase inhibitors
MX2009011210A (es) Inhibidores de mcl1 de indol 7-no sustituido.
ZA201001304B (en) Compositions for the treatment of neoplastic diseases
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
MX2009011211A (es) Indoles sustituidos en la posicion 7 inhibidores de mci-1.
PH12014500053A1 (en) Proteasome inhibitors
MX2009008798A (es) Derivados de iminipiridina y sus usos como microbicidas.
MX340064B (es) Derivados de azaadamantano y sus usos como ligandos de receptores de acetilcolina nicotinicos.
TN2009000291A1 (en) Inhibitors of mek
JO3007B1 (ar) مركبات و تركيبات كمثبطات كيناز بروتين
TW200626068A (en) Active compounds for seed treatment
MY166653A (en) Derivatives of 1-amino-2-cyclobutylethylboronic acid
ECSP088306A (es) Agentes para prevenir y tratar los trastornos que involucran la modulación de los receptores ryr
GB0920703D0 (en) Compositions containing satiogens and methods of use
TN2011000291A1 (en) Purine compounds
EA201000895A1 (ru) Композиции и способы для лечения лизосомных болезней
EA201100874A1 (ru) Соединения для лечения рака
MX337849B (es) Composiciones y metodos para inhibicion de la via jak.
MX2013002851A (es) Inhibidores de tonum pectinacetilesterasa y metodos de su uso.
IL187715A0 (en) Use of phenylsemicarbazones for seed treatment
EA201170344A1 (ru) Азаиндольные ингибиторы iap
TW200639155A (en) Thiazolidinones, their production and use as pharmaceutical agents
EP2398789A4 (en) SPIROPYRROLIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
IN2012DN01223A (es)
MX2009012079A (es) Compuestos heterociclicos condensados como inhibidores de proteina cinasas.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal